develop
safe
effect
tetraval
dengu
vaccin
elicit
protect
dengu
viru
denv
serotyp
urgent
need
consensu
sequenc
ectodomain
envelop
e
protein
denv
examin
immunogen
previous
current
studi
dna
vaccin
construct
evalu
conjunct
protein
p
vaccin
examin
whether
vaccin
use
togeth
improv
immun
respons
dna
vaccin
administr
use
either
homolog
dna
alon
ddd
heterolog
dna
primeprotein
boost
ddp
dpp
regimen
evalu
immunogen
protect
efficaci
mice
among
three
dnabas
immun
regimen
test
ddp
immun
optim
immun
regimen
elicit
greatest
system
immun
respons
confer
protect
four
denv
serotyp
work
provid
innov
idea
develop
consensu
ebas
dengu
vaccin
test
optim
immun
regimen
dengu
virus
denv
belong
genu
flaviviru
famili
flavivirida
includ
sever
major
human
pathogen
zika
viru
japanes
enceph
viru
jev
yellow
fever
viru
yfv
lazear
diamond
four
distinct
close
relat
serotyp
denv
caus
wide
rang
clinic
present
includ
dengu
fever
dengu
hemorrhag
fever
dengu
shock
syndrom
dengu
one
preval
mosquitoborn
viral
diseas
tropic
subtrop
countri
estim
million
annual
case
miksanek
wolford
past
year
incid
dengu
increas
expand
transmiss
urban
rural
set
stanaway
et
al
aggarw
garg
make
signific
intern
public
health
problem
costeffect
public
health
tool
vaccin
indispens
address
global
burden
dengu
thu
develop
vaccin
dengu
urgent
need
variou
dengu
tetraval
vaccin
candid
current
clinic
preclin
stage
develop
kirkpatrick
et
al
sirivichayakul
et
al
saezlloren
et
al
whitehead
et
al
base
mostli
combin
four
antigen
repres
four
denv
serotyp
singl
tetraval
formul
cydtdv
first
licens
tetraval
dengu
vaccin
approv
thirteen
dengu
epidem
countri
ferguson
et
al
henein
et
al
compris
four
monoval
dengu
vaccin
made
replac
gene
encod
precursor
membran
envelop
e
protein
denv
serotyp
correspond
gene
backbon
recent
studi
reanalyz
data
three
efficaci
trial
cydtdv
vaccin
discov
despit
vaccin
confer
protect
sever
dengu
hospit
dengu
seroposit
subject
year
vaccin
put
dengu
individu
higher
risk
infect
diseas
sridhar
et
al
new
data
prompt
chang
vaccin
label
vaccin
maker
reapprais
cydtdv
vaccin
strategi
report
strateg
advisori
group
expert
wildersmith
et
al
experiment
tetraval
dengu
vaccin
show
promis
clinic
test
vaccin
initi
develop
nation
institut
allergi
infecti
diseas
unit
state
licens
compani
takeda
phase
ii
studi
conduct
dengueendem
nonendem
countri
elicit
robust
neutral
antibodi
nab
respons
four
denv
serotyp
welltoler
subject
georg
et
al
rupp
et
al
saezlloren
et
al
current
test
phase
iii
clinic
trial
brazil
whitehead
et
al
experiment
dengu
vaccin
also
develop
recent
review
de
soarez
et
al
gener
believ
nonneutr
crossreact
antibodi
respons
induc
certain
denv
serotyp
may
increas
risk
develop
sever
diseas
upon
secondari
infect
differ
denv
serotyp
due
antibodydepend
enhanc
ade
therefor
import
develop
tetraval
vaccin
capabl
induc
balanc
immun
respons
broad
protect
four
denv
serotyp
simultan
instead
use
four
separ
compon
singl
vaccin
repres
epitop
consensu
sequenc
multipl
strain
serotyp
denv
may
novel
vaccin
strategi
need
explor
develop
bioinformat
comput
approach
brought
versatil
vaccin
design
instanc
epitopebas
vaccin
design
appli
varieti
pathogen
immun
respons
could
induc
convent
vaccin
sett
et
al
sett
fike
consensu
sequencebas
vaccin
strategi
appli
develop
immunogen
elicit
broadli
reactiv
crossreact
protect
respons
influenza
viru
human
immunodefici
viru
hiv
denv
genet
complex
pathogen
carter
et
al
meyerhoff
et
al
sun
et
al
wang
et
al
mani
studi
demonstr
consensu
predict
could
outperform
singl
sequenc
determin
method
vaccin
design
mallio
moutaftsi
et
al
yan
et
al
importantli
conserv
region
also
variabl
site
could
incorpor
consensu
sequenc
design
seem
alter
structur
function
properti
target
protein
given
locat
schein
et
al
e
glycoprotein
denv
consid
import
antigen
dengu
vaccin
develop
major
compon
surfac
denv
primari
target
nab
trent
beltramello
et
al
e
protein
ectodomain
ntermin
truncat
amino
rich
serotypespecif
neutral
crossreact
epitop
appli
wide
diagnost
vaccin
develop
jarvi
et
al
achiev
much
coverag
possibl
four
denv
serotyp
logic
construct
recombin
product
compos
critic
neutral
epitop
serotyp
denv
rivet
epitop
highli
conserv
region
viru
use
consensu
sequenc
reason
option
target
differ
serotyp
denv
thu
previous
design
vaccin
base
conserv
region
e
protein
ectodomain
name
consensusbas
assess
immunogen
vivo
sun
et
al
result
show
immun
three
dose
recombin
protein
vaccin
capabl
elicit
respons
nab
respons
four
denv
serotyp
mice
sun
et
al
order
trigger
broader
immun
respons
especi
cellular
immun
respons
improv
potenti
protect
efficaci
candid
vaccin
new
dna
vaccin
express
construct
test
conjunct
protein
current
studi
use
either
homolog
dna
immun
regimen
heterolog
dna
primeprotein
boost
regimen
result
demonstr
among
three
dnabas
immun
regimen
two
dna
prime
plu
one
protein
boost
regimen
evok
strongest
humor
cellular
immun
respons
four
denv
serotyp
confer
protect
mice
infect
four
serotyp
dengu
virus
work
provid
new
insight
develop
tetraval
dengu
vaccin
vero
cell
cultur
minim
essenti
medium
gibco
unit
state
supplement
fetal
bovin
serum
fb
gibco
unit
state
c
cell
cultur
medium
gibco
unit
state
supplement
fb
c
cell
cultiv
humidifi
atmospher
co
hawaii
strain
strain
strain
strain
propag
cell
store
c
freezer
denv
particl
harvest
cultur
supernat
cell
infect
denv
concentr
polyethylen
glycol
precipit
purifi
clarifi
extract
ultracentrifug
femal
balbc
mice
purchas
beij
vital
river
laboratori
anim
technolog
co
ltd
anim
experi
perform
accord
regul
administr
affair
concern
experiment
anim
nation
guidelin
care
use
anim
scientif
research
experiment
procedur
approv
institut
anim
care
use
committe
capit
medic
univers
china
gene
encod
consensu
sequenc
max
silico
calcul
synthes
describ
previous
sun
et
al
sequenc
nucleotid
homolog
amino
acid
homolog
sequenc
four
repres
denv
serotyp
supplementari
tabl
match
serotyp
denv
predict
amino
acid
level
shown
supplementari
figur
construct
recombin
plasmid
express
protein
kozak
sequenc
signal
sequenc
vesicular
stomat
viru
glycoprotein
mkcllylaflfigvnc
ad
upstream
dna
sequenc
supplementari
text
ecori
noti
site
insert
upstream
translat
start
codon
downstream
termin
codon
respect
final
synthet
sequenc
subclon
ecori
noti
site
vector
hereinaft
pv
name
baculovirusexpress
protein
use
immun
construct
purifi
describ
previous
sun
et
al
mice
divid
group
receiv
either
homolog
heterolog
primeboost
vaccin
supplementari
tabl
shown
figur
mice
group
immun
three
time
interv
homolog
immun
regimen
mice
immun
normal
salin
intramuscular
im
inject
anterior
tibiali
muscl
vivo
electropor
ep
describ
previous
wang
et
al
group
design
ddd
control
mice
administr
equal
quantiti
pv
heterolog
primeboost
immun
regimen
mice
either
inocul
im
vivo
ep
method
follow
boost
subcutan
sc
twice
protein
emulsifi
alhydrogel
r
adjuv
dpp
prime
twice
follow
boost
protein
ddp
two
correspond
control
group
given
im
oncetwic
pv
vivo
ep
method
follow
sc
twiceonc
equal
volum
adjuv
detect
denvspecif
igg
antibodi
subset
well
plate
coat
purifi
viral
particl
plate
block
bovin
serum
albumin
elisa
perform
accord
report
method
wang
et
al
sera
immun
mice
twofold
serial
dilut
pb
denvspecif
antibodi
detect
goatantimous
secondari
antibodi
hrp
coupl
abcam
unit
state
substrat
solut
tetramethylbenzidin
optic
densiti
od
nm
measur
use
elisa
reader
thermo
fisher
scientif
unit
state
reciproc
highest
dilut
yield
od
valu
greater
one
half
od
valu
correspond
control
dilut
record
endpoint
titer
igg
antibodi
detect
igg
subclass
sera
immun
mice
dilut
use
primari
antibodi
level
igg
subclass
express
od
valu
antidenv
nab
titer
measur
use
prnt
describ
previous
wang
et
al
hawaii
strain
strain
strain
strain
use
test
heat
inactiv
c
min
twofold
serial
dilut
sera
mix
denv
suspens
contain
plaqueform
unit
pfu
incub
c
h
mixtur
transfer
vero
cell
monolay
plate
incub
c
anoth
h
infect
vero
cell
wash
overlaid
mem
contain
methylcellulos
plaqu
stain
count
day
incub
c
reciproc
highest
serum
dilut
correspond
reduct
averag
number
plaqu
viru
infect
well
determin
neutral
titer
prnt
antibodi
stain
reagent
purchas
bd
bioscienc
unit
state
red
blood
cell
lysi
splenocyt
block
rat
antimous
monoclon
antibodi
stimul
ml
purifi
particl
h
cell
splenocyteproduc
determin
use
elispot
kit
bd
unit
state
previous
describ
wang
et
al
brief
splenocyt
isol
immun
mice
aliquot
well
filtrat
plate
millipor
unit
state
precoat
captur
antibodi
stimul
purifi
denv
particl
h
c
incub
biotinyl
detect
antibodi
streptavidinhrp
respect
spot
visual
ad
substrat
count
elispot
reader
ctl
unit
state
analyz
immunospot
softwar
version
investig
protect
efficaci
vaccin
candid
mice
challeng
week
last
vaccin
intracerebr
ic
either
pfu
hawaii
strain
pfu
strain
pfu
strain
pfu
strain
individu
bodi
weight
chang
individu
mous
surviv
rate
monitor
daili
day
statist
analys
perform
use
spss
version
spss
inc
unit
state
sequenc
align
homolog
analyz
dnastar
softwar
version
unit
state
differ
mean
bodi
weight
chang
group
analyz
repeat
measur
analysi
varianc
anova
kaplanmei
surviv
curv
plot
evalu
statist
logrank
test
comparison
group
analyz
use
oneway
anova
result
present
mean
standard
deviat
sd
differ
mean
consid
signific
p
signific
p
extrem
signific
p
determin
vaccin
regimen
elicit
effect
immun
respons
dna
protein
vaccin
first
examin
antigen
specif
fluoresc
signal
observ
cytoplasm
transient
transfect
cell
indic
plasmidexpress
protein
could
recogn
antibodi
four
serotyp
denv
vitro
could
use
subsequ
experi
supplementari
figur
compar
three
immun
strategi
includ
thrice
dna
ddd
dna
prime
twice
plu
protein
boost
ddp
dna
prime
plu
protein
boost
twice
dpp
figur
supplementari
tabl
humor
cellular
immun
respons
cytokin
respons
protect
efficaci
determin
first
establish
optim
experiment
condit
three
week
last
immun
ddd
vaccin
group
geometr
mean
titer
gmt
igg
confid
interv
ci
wherea
gmt
control
group
ci
p
figur
next
neutral
capac
antibodi
measur
prnt
gmt
nab
reach
ci
follow
ddd
regimen
none
control
pvadministr
mice
show
detect
nab
activ
less
p
figur
data
demonstr
ddd
regimen
induc
humor
immun
respons
mice
mice
immun
via
heterolog
primeboost
regimen
dpp
ddp
induc
significantli
higher
igg
titer
gmt
ci
ci
dpp
ddp
regimen
respect
higher
homolog
ddd
immun
group
p
figur
similar
result
higher
nab
titer
also
observ
sera
nab
prnt
titer
ci
ci
dpp
ddp
regimen
respect
greater
ddd
regimen
character
specif
profil
igg
antibodi
induc
differ
vaccin
regimen
immun
sera
analyz
elisa
figur
mice
known
product
assist
respons
wherea
product
help
respons
germann
et
al
thu
analyz
antibodi
subclass
distribut
deduc
cell
subset
activ
differ
vaccin
result
show
ddd
vaccin
regimen
mainli
elicit
antibodi
subclass
comparison
heterolog
regimen
dpp
ddp
evok
antibodi
subclass
includ
data
indic
heterolog
vaccin
could
induc
better
igg
diversif
homolog
regimen
impli
better
cell
activ
take
togeth
data
show
among
vaccin
regimen
test
mice
immun
ddp
regimen
develop
strongest
humor
immun
respons
homolog
ddd
regimen
induc
weakest
dpp
perform
cell
respons
analyz
week
third
vaccin
first
investig
central
high
high
effector
high
low
memori
cell
upon
stimul
antigen
cell
mice
receiv
three
immun
regimen
show
robust
central
effector
memori
cell
respons
notabl
highest
proport
figur
cell
respons
elicit
differ
immun
regimen
repres
express
high
cell
gate
cell
quantif
frequenc
b
high
high
c
high
low
cell
among
cell
data
express
mean
sd
n
p
p
p
central
figur
b
effector
memori
cell
figur
c
observ
ddp
regimen
significantli
higher
ddd
dpp
regimen
dpp
regimen
also
show
higher
proport
effector
memori
cell
popul
central
memori
cell
ddd
regimen
figur
c
result
suggest
heterolog
vaccin
especi
ddp
regimen
effect
induc
cell
expans
examin
whether
vaccin
could
activ
cell
equal
week
final
immun
measur
gener
cytokin
upon
stimul
purifi
particl
level
repres
indic
cell
respons
measur
elispot
assay
mice
vaccin
three
immun
regimen
significantli
trigger
respons
compar
control
figur
b
dpp
regimen
induc
ddd
regimen
figur
ddp
regimen
elicit
highest
level
respons
figur
b
significantli
higher
ddd
regimen
p
result
indic
heterolog
ddp
regimen
effect
induc
cytokin
respons
regimen
examin
whether
vaccin
induc
immun
respons
associ
protect
week
final
vaccin
mous
challeng
ic
pfu
protect
effect
evalu
observ
period
mice
control
group
show
bodi
weight
loss
figur
none
surviv
viral
challeng
figur
e
contrast
mean
bodi
weight
loss
ddd
group
signific
less
control
p
figur
surviv
viral
challeng
p
ddd
vs
control
figur
dpp
group
show
even
less
daili
bodi
weight
loss
control
p
figur
also
surviv
rate
p
figur
note
ddp
vaccin
regimen
protect
mice
p
figur
show
obviou
bodi
weight
loss
p
figur
thu
result
show
among
three
dnabas
immun
regimen
heterolog
ddp
figur
cytokinesecret
splenocyt
differ
immun
group
cytokinesecret
splenocyt
determin
stimul
purifi
particl
posit
splenocyt
count
express
mean
cell
b
splenocyt
repres
elispot
imag
respect
data
express
mean
sd
n
p
p
primeboost
regimen
optim
strategi
confer
effect
protect
concurr
induct
highest
nab
level
activ
cell
elicit
respons
establish
optim
vaccin
strategi
singl
dengu
serotyp
want
explor
whether
use
ddp
primeboost
regimen
could
induc
tetraval
immun
respons
four
dengu
serotyp
three
week
last
vaccin
use
vaccin
ddp
regimen
consider
igg
respons
gener
gmt
ci
ci
respect
robust
respons
also
induc
titer
ci
ci
respect
tabl
similarli
tetraval
neutral
antibodi
gener
vaccin
four
denv
serotyp
prnt
titer
ci
ci
ci
ci
tabl
next
examin
cell
respons
induc
ddp
regimen
three
figur
protect
efficaci
challeng
differ
immun
regimen
mice
immun
differ
regimen
challeng
ic
monitor
daili
bodi
weight
surviv
rate
consecut
day
n
ac
percentag
chang
bodi
weight
day
determin
weight
postchalleng
weight
prechalleng
data
express
mean
sd
df
surviv
rate
shown
percentag
survivor
p
p
p
p
valu
analyz
oneway
anova
compar
titer
vaccin
subgroup
control
subgroup
n
p
p
p
gmt
geometr
mean
titer
week
final
immun
splenocyt
isol
stimul
purifi
particl
individu
neg
posit
control
measur
level
result
show
figur
respons
figur
elicit
investig
whether
observ
tetraval
immun
respons
induc
vaccin
could
confer
protect
denv
serotyp
week
last
boost
mice
vaccin
ddp
regimen
challeng
ic
separ
figur
challeng
mean
bodi
weight
loss
statist
lower
control
p
figur
b
challeng
vaccin
mice
bodi
weight
loss
significantli
lower
control
p
figur
moreov
higher
surviv
rate
prolong
surviv
time
observ
vaccin
mice
control
p
figur
taken
togeth
result
demonstr
immun
ddp
regimen
could
induc
protect
immun
four
serotyp
denv
heterolog
ddp
immun
regimen
use
singl
consensusbas
vaccin
effect
improv
system
immun
respons
ideal
dengu
vaccin
appropri
vaccin
regimen
urgent
need
solv
dengu
problem
global
scale
studi
first
compar
three
vaccin
regimen
dna
protein
vaccin
contain
sequenc
either
ddd
ddp
dpp
format
demonstr
ddp
optim
method
induc
robust
neutral
antibodi
strong
antigenspecif
cell
respons
effect
protect
consensu
sequenc
code
target
antigen
wide
appli
vaccin
develop
induc
univers
specif
immun
respons
especi
virus
high
degre
genet
variat
influenza
viru
hiv
yan
et
al
yang
et
al
previous
base
consensu
sequenc
ectodomain
e
protein
denv
strain
includ
four
denv
serotyp
design
construct
tetraval
subunit
vaccin
design
singl
immunogen
rather
convent
tetraval
formul
four
individu
vaccin
compon
might
mechanist
avoid
either
potenti
interfer
among
four
compon
immun
domin
particular
antigen
compon
specif
serotyp
moreov
reduc
cost
complex
product
tetraval
vaccin
inde
shown
homolog
immun
three
dose
protein
suffici
induc
bind
tetraval
nab
type
immun
respons
sun
et
al
dna
vaccin
mani
advantag
simplic
manufactur
eas
prepar
costeffect
biolog
stabil
dhama
et
al
fact
tetraval
figur
protect
efficaci
induc
ddp
immun
regimen
mice
immun
ddp
regimen
challeng
ic
monitor
daili
day
n
percentag
chang
bodi
weight
day
challeng
b
c
percentag
determin
weight
postchalleng
weight
prechalleng
data
express
mean
sd
surviv
rate
post
challeng
shown
percentag
survivor
p
p
dengu
dna
vaccin
test
phase
clinic
trial
demonstr
safeti
toler
capac
elicit
denvspecif
respons
danko
et
al
also
demonstr
dna
vaccin
capabl
induc
balanc
immun
respons
effect
protect
denv
zheng
et
al
protein
dna
vaccin
test
togeth
found
homolog
immun
three
dose
dna
ddd
less
effect
heterolog
primeboost
regimen
dpp
ddp
use
protein
combin
specif
reason
observ
unclear
possibl
could
consid
homolog
dna
immun
previou
work
show
immunogen
dose
enough
induc
strong
immun
respons
protect
mice
wang
et
al
howev
studi
immun
three
dose
dna
induc
modest
immun
respons
protect
reveal
limit
antibodi
titer
cell
respons
surviv
rate
challeng
may
due
mismatch
sequenc
vaccin
challeng
viru
contrast
heterolog
immun
regimen
mice
immun
use
dpp
ddp
regimen
trigger
effect
humor
cellular
immun
respons
well
cytokin
respons
effect
protect
compar
ddd
particular
ddp
immun
regimen
induc
strongest
immun
respons
protect
among
vaccin
regimen
test
figur
indic
obviou
advantag
ddp
due
probabl
protein
boost
memori
b
cell
respons
conserv
antigen
elicit
dna
doubl
prime
result
consist
similar
studi
de
filett
et
al
report
dna
primeprotein
boost
immun
strategi
could
result
mark
increas
nab
titer
complet
protect
lethal
west
nile
viru
wnv
infect
compar
inject
e
protein
wnv
alon
kadkhodayan
et
al
demonstr
dna
primeprotein
boost
regimen
significantli
improv
specif
cell
respons
antibodi
respons
hiv
influenza
viru
compar
dna
protein
vaccin
alon
howev
previou
attempt
induc
broad
protect
multipl
denv
serotyp
encount
difficulti
apt
et
al
raviprakash
et
al
develop
three
recombin
denv
e
dna
construct
contain
share
epitop
four
denv
use
dna
shuffl
screen
technolog
discov
homolog
vaccin
shuffl
construct
provid
limit
protect
either
vaccin
anim
similarli
also
limit
immunogen
vaccin
dna
studi
contrast
heterolog
vaccin
regimen
induc
high
level
memori
cell
also
elev
antibodi
respons
confer
protect
four
serotyp
denv
thu
tactic
dna
prime
follow
protein
boost
may
suitabl
develop
denv
vaccin
vaccin
de
filett
et
al
wang
et
al
complet
clear
heterolog
vaccin
regimen
produc
better
immun
respons
homolog
immun
theoret
immun
respons
elicit
dna
protein
associ
rout
antigen
deliveri
mode
antigen
present
bor
tlymphocyt
dna
vaccin
use
host
cell
machineri
vivo
synthesi
target
antigen
deliv
intraor
extracellular
pathway
trigger
mhci
mhcii
restrict
cell
immun
respons
moreov
intracellular
antigen
express
dna
vaccin
tend
fold
nativ
conform
correctli
glycosyl
form
may
display
neutral
epitop
similar
pattern
nativ
viru
contrast
protein
vaccin
deliv
exogen
host
cell
mostli
elicit
antibodi
respons
connect
mhcii
pathway
antigen
present
reason
dna
often
use
prime
antigen
presensit
antigenspecif
memori
b
cell
increas
quantiti
divers
cell
clone
time
stimul
cell
activ
proteinboost
stimul
memori
b
cell
divid
differenti
plasma
cell
secret
antibodi
greater
magnitud
letelli
et
al
ranasingh
ramshaw
accordingli
activ
humor
cellular
immun
respons
dna
follow
boost
protein
vaccin
heterolog
vaccin
regimen
like
effect
induc
protect
immun
interestingli
found
ddp
regimen
offer
protect
efficaci
dpp
regimen
studi
mechan
observ
specul
moment
antigen
mostli
express
local
myocyt
andor
keratinocyt
dna
vaccin
singl
prime
dna
prime
dpp
regimen
may
present
low
amount
antigen
gener
longliv
antibodysecret
plasma
cell
popul
induc
potent
highaffin
antibodi
respons
possibl
establish
small
number
nonantibodi
secret
memori
b
cell
comparison
ddp
regimen
protein
boost
adjuv
follow
two
dna
immun
antibodysecret
memori
b
cell
could
activ
recruit
langerhan
cell
inject
site
drain
lymph
node
could
stimul
porgador
et
al
kahlon
et
al
could
contribut
better
induct
antibodi
respons
intric
interact
vaccin
process
might
explain
ddp
regimen
led
induct
higher
level
antibodi
cytokin
respons
confer
effect
protect
ddd
dpp
taken
togeth
result
suggest
heterolog
ddp
immun
regimen
would
advantag
significantli
improv
respons
simultan
respons
avil
et
al
wang
et
al
cao
et
al
jung
et
al
therefor
ddp
vaccin
regimen
would
appropri
strategi
develop
dengu
vaccin
whether
principl
appli
vaccin
antigen
need
investig
also
evalu
whether
ddp
vaccin
regimen
could
evok
immun
respons
protect
three
denv
serotyp
significantli
ddp
vaccin
induc
significantli
level
cytokin
respons
upon
vitro
stimul
purifi
particl
figur
high
level
igg
nab
respons
four
denv
serotyp
also
protect
figur
studi
bodi
weight
chang
use
evalu
vivo
protect
efficaci
mice
challeng
bodi
weight
loss
observ
challeng
vaccin
group
mice
bodi
weight
loss
control
case
challeng
ddp
immun
provid
surviv
rate
significantli
less
bodi
weight
loss
control
combin
result
result
indic
vaccin
use
ddp
immun
regimen
could
induc
tetraval
protect
infect
four
denv
serotyp
therefor
repres
promis
immun
strategi
develop
dengu
vaccin
limit
studi
firstli
among
four
serotyp
denv
rel
preponder
immun
respons
reveal
highest
titer
igg
nab
tabl
may
relat
fact
sequenc
share
highest
homolog
amino
acid
shortest
evolutionari
distanc
phylogenet
cluster
togeth
sun
et
al
secondli
contain
mani
predict
epitop
within
supplementari
figur
tabl
factor
could
contribut
robust
humor
immun
respons
protect
immun
denv
schein
et
al
addit
grow
consensu
cell
immun
respons
play
import
role
protect
induc
dengu
vaccin
lam
et
al
report
stronger
cell
respons
requir
nonstructur
protein
ns
although
cell
epitop
within
e
protein
yauch
et
al
lack
ns
protein
also
flaw
recombin
vaccin
candid
studi
modif
vaccin
design
includ
ns
gene
might
improv
cellular
immun
respons
balanc
among
tetraval
immun
respons
induc
singl
dengu
vaccin
although
develop
dengu
dna
vaccin
problemfre
recent
studi
indic
zika
dna
vaccin
highli
effect
gener
robust
humor
cellular
immun
respons
mice
monkey
dowd
et
al
hampton
griffin
et
al
structur
genet
close
zikv
denv
success
zika
dna
vaccin
like
inform
ration
develop
dengu
dna
vaccin
extens
previou
work
protein
p
vaccin
studi
examin
whether
ad
dna
vaccin
encod
antigen
three
vaccin
regiment
ddd
ddp
dpp
augment
efficaci
vaccin
found
among
three
dnabas
immun
regimen
ddp
regimen
optim
regimen
enabl
gener
strong
rel
balanc
humor
cellular
immun
respons
four
serotyp
denv
well
desir
cytokin
respons
importantli
vaccin
candid
use
ddp
regimen
afford
effect
protect
challeng
four
serotyp
denv
result
first
time
demonstr
vaccin
singl
dengu
viru
deriv
sequenc
confer
tetraval
protect
mice
result
offer
prototyp
denv
vaccin
could
improv
test
nonhuman
primat
model
eventu
human
clinic
trial
anim
experi
perform
accord
regul
administr
affair
concern
experiment
anim
nation
guidelin
care
use
anim
scientif
research
experiment
procedur
approv
institut
anim
care
use
committe
capit
medic
univers
china
rw
design
perform
experi
analyz
data
wrote
manuscript
xz
js
kf
ng
df
help
experiment
design
xj
design
codonoptim
sequenc
hc
design
research
analyz
data
wrote
manuscript
ja
design
princip
research
supervis
project
draft
manuscript
supplementari
materi
articl
found
onlin
http
supplementarymateri
figur
character
amino
acid
residu
vitro
express
distribut
predict
amino
acid
residu
along
sequenc
align
protein
line
number
residu
posit
line
red
rhombus
predict
protein
bind
region
line
dark
red
blue
bar
dark
red
bar
repres
helix
blue
bar
repres
strand
line
blue
white
yellow
bar
blue
bar
repres
region
expos
surfac
white
yellow
bar
repres
intermedi
buri
region
line
green
bar
disord
region
predict
featur
creat
onlin
websit
http
openpredictproteinorg
b
vitro
express
cell
transfect
recombin
plasmid
transient
express
protein
examin
indirect
immunofluoresc
assay
fixat
paraformaldehyd
cell
permeabil
triton
phosphat
buffer
solut
block
bovin
serum
albumin
immun
sera
obtain
mice
infect
use
primari
antibodi
cell
stain
goatantimous
iggfitc
green
counterstain
dapi
blue
identifi
cell
nuclei
white
bar
repres
text
sequenc
